Search results
Results from the WOW.Com Content Network
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.
After WWII was over and the reports declassified, the experiences converged and led researchers to look for other substances that might have similar effects against cancer. The first chemotherapy drug to be developed from this line of research was mustine. Since then, many other drugs have been developed to treat cancer, and drug development ...
Though 80–90 percent of cancer pain can be eliminated or well controlled, nearly half of all people with cancer pain in the developed world and more than 80 percent of people with cancer worldwide receive less than optimal care. [28] Cancer changes over time, and pain management needs to reflect this.
The increased risk is believed to be due to the random chance of developing any cancer, the likelihood of surviving the first cancer, the same risk factors that produced the first cancer, unwanted side effects of treating the first cancer (particularly radiation therapy), and better compliance with screening.
Childhood cancer is cancer in a child. About 80% of childhood cancer cases in high-income countries can be successfully treated via modern medical treatments and optimal patient care. [2] [3] However, only about 10% of children diagnosed with cancer reside in high-income countries where the necessary treatments and care is available.
Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer. [6] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer. [7]
A new study about cancer is providing a glimmer of hope. It says that by the year 2050, the disease will kill almost no one under the age of 80. Increased efforts to discover cancer treatments led ...
Patients with CLL have an increased risk of developing serious infections. [13] Thus, they should be routinely monitored and promptly treated with antibiotics if an infection is present. [13] In patients with significant signs or symptoms, treat can involve chemotherapy, immunotherapy, or chemoimmunotherapy. [4]